| Literature DB >> 25428213 |
Joanna Gesche1, Kristina Renault, Kirsten Nørgaard, Lisbeth Nilas.
Abstract
OBJECTIVE: To examine the representativeness of participants attending a lifestyle intervention study addressing obese pregnant women.Entities:
Mesh:
Year: 2014 PMID: 25428213 PMCID: PMC5644893 DOI: 10.1159/000369769
Source DB: PubMed Journal: Obes Facts ISSN: 1662-4025 Impact factor: 3.942
Fig. 1Flow-chart of the study population. 1Obese: BMI > 30 kg/m2. 216 due to linguistic problems, 9 due to competing diseases; 9 were added to the non-participants.
Baseline data in participants and non – participants in a lifestyle intervention trial in obese pregnant womena
| Participants (n = 425) | Non-participants (n = 249) | Significance | |
|---|---|---|---|
| BMI, mean (SD), kg/m2 | 34.1 (4.0) | 33.9 (3.8) | 0.66 |
| Median, range | 32.8 (29.0–52.2) | 32.9 (27.1–46.5) | |
| 30.0–34.9, % | 67.1 | 67.0 | |
| 35.0–39.9, % | 22.1 | 18.1 | |
| >40, % | 9.9 | 10.9 | |
|
| |||
| Age, mean (SD), years | 31.1 (4.5) | 29.9 (4.9) | <0.05 |
| Median (range) | 31.1 (18–44) | 30.0 (18–41) | |
| <25 years, % | 8.7 | 15.3 | |
| 25–30 years, % | 32.2 | 31.7 | <0.05 |
| >30 years, % | 59.1 | 53.0 | |
|
| |||
| Parity, mean (SD) | 0.55 (0.72) | 0.83 (0.89) | |
| Median (range) | 0 (1–4) | 1 (0–5) | |
| Nulliparous, % | 55.7 | 42.5 | <0.001 |
| Uniparous, % | 35.1 | 37.0 | |
| Multiparous, % | 9.2 | 20.5 | |
|
| |||
| Danish nationality, % | 91.8 | 68.5 | <0.001 |
|
| |||
| Married/cohabitating, % | 90.1 | 86.6 | <0.05 |
|
| |||
| Smokers, % | 8.1 | 19.5 | <0.001 |
|
| |||
| Social status – women, % | |||
| No education | 7.2 | 10.0 | 0.40 |
| Secondary school / occupational training | 46.4 | 41.6 | |
| University studies | 39.5 | 39.4 | |
| PhD student | 6.9 | 9.0 | |
Wilcocxon's rank sum test
chi-squared test.
Attendance to scheduled oral glucose tolerance test (OGTT) at gestational weeks and the 2-hour plasma glucose concentrations in obese pregnant women participating and not participating in a lifestyle intervention trial. Values are given as mean (SD) or percentages
| Participants (n = 425) | Non-participants (n = 249) | Significance | |
|---|---|---|---|
| OGTT at week 14–20, % | 89.6 | 84.7 | 0.08 |
| OGTT at week 27–30, % | 81.6 | 43.0 | <0.001 |
| 2-hour glucose, mmol/l | 7.0 (1.3) | 7.0 (1.2) | 1.0 |
| >10 mmol/l week 14–20, % | 3.1 | 3.3 | |
| 2-hour glucose, mmol/l | 6.8 (1.3) | 6.9 (1.4) | 1.0 |
| >10 mmol/l week 27–30, % | 2.0 | 1.9 | |
Chi-squared test.
Pregnancy outcome in participants and non-participants in a lifestyle intervention trial in obese pregnant women
| Outcome | Participants (n = 134) | Non-participants (n = 231) | Significance |
|---|---|---|---|
| Gestational age (SD), days | 278 (12) | 276 (15) | 0.19 |
|
| |||
| Fetal weight, g | |||
| Mean (SD) | 3,608 (549) | 3,518 (587) | 0.13 |
| Median (range) | 3,641 (1,223–5,280) | 3,540 (480–5,040) | |
| <2,500, % | 3.0 | 3.9 | 0.54 |
| >4,000, % | 24.6 | 17.7 | |
| Z-score mean | 2.4 (13.3) | 1.3 (13.5) | |
| Z-score median | 1.0 (–40 to 37) | 0 (–64 to 49) | |
| Z-score < 22 (%) | 1.5 | 2.6 | |
|
| |||
| Fetal length (SD), cm | 52.0 (2.6) | 51.7 (3.0) | 0.29 |
|
| |||
| Placental weight (SD), g | 671 (163) | 679 (155) | 0.45 |
|
| |||
| Arterial umbilical cord pH (SD) | 7.23 (0.08) | 7.25 (0.09) | 0.22 |
|
| |||
| Vaginal delivery, % | 62.7 | 67.5 | 0.41 |
| Non-instrumental | 85.7 | 87.2 | |
| Instrumental | 14.3 | 12.8 | |
| Cesarean section, % | 37.3 | 32.5 | 0.06 |
| Acute | 64.0 | 45.3 | |
| Elective | 36.0 | 54.7 | |
| Epidural, % | 42.2 | 40.5 | 0.86 |
The effect of participating in a randomized controlled study on attendance to OGTT and pregnancy outcome with and without adjusting for age and nationality
| Outcome | Unadjusted | Adjusted for age | Adjusted for nationality |
|---|---|---|---|
| Show up to OGTT at week 14–20, % | 1.56 (0.98–2.48) | 1.59 (0.99–2.53) | 1.37 (0.81–2.33) |
|
| |||
| Show up to OGTT at week 27–30, % | 5.90 (4.17–8.42) | 6.05 (4.26–8.67) | 5.80 (3.88–8.84) |
|
| |||
| Blood glucose OGTT 1 | 0.02 (–0.29 to 0.24) | 0.02 (–0.20 to 0.24) | (–0.24 to 0.26) |
|
| |||
| Blood glucose OGTT2 | –0.01 (–0,29 to 0.27) | (–0.30 to 0.26) | –0.12 (–0.43 to 0.18) |
|
| |||
| Diagnosed with GDM | 1.44 (0.90–2.28) | 1.44 (0.90–2.29) | 1.12 (0.47–2.51) |
|
| |||
| Gestational age, days | 1.90 (–1.04 to 4.84) | 1.57 (–1.38 to 4.52) | 1.46 (–2.20 to 5.13) |
|
| |||
| Fetal weight, g | 90.43 (–31.98 to 212.84) | 69.80 (–52.44 to 192.03) | 109.78 (–43.78 to 263.35) |
|
| |||
| Fetal length, cm | 0.28 (–0.33 to 0.89) | 0.17 (–0.44 to 0.78) | 0.36 (–0.41 to 1.13) |
|
| |||
| Placental weight, g | 87.65 (–22.66 to 197.95) | 94.08 (–17.06 to 205.22) | 96.10 (–42.31 to 234.51) |
|
| |||
| Arterial umbilical cord pH | –0.01 (–0.03 to 0.01) | –0.01 (–0.03 to 0.01) | –0.002 (–0.03 to 0.02) |
|
| |||
| Vaginal delivery, % | 16.8 (9.68–30.30) | 17.40 (9.93–31.77) | 11.66 (5.96–24.45) |
| Cesarean section, % | 1.21 (0.78–1.89) | 1.15 (0.73–1.80) | 1.44 (0.82–2.58) |
| Acute | 1.76 (1.03–3.00) | 1.73 (1.01–2.97) | 1.57 (0.81–3.13) |
| Elective | 0.72 (0.39–1.29) | 0.67 (0.36–1.21) | 1.08 (0.49–2.41) |
| Epidural (%) | 1.15 (0.74–1.80) | 1.23 (0.78–1.94) | 1.17 (0.67–2.07) |